• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素和依诺肝素对脱套伤影响的分析

Analysis of the effects of heparin and enoxaparin on degloving injuries.

作者信息

Cebesoy O, Isik M, Erzincan T, Pamukcu U, Bilgin F, Subasi M

出版信息

Bratisl Lek Listy. 2014;115(9):550-3. doi: 10.4149/bll_2014_106.

DOI:10.4149/bll_2014_106
PMID:25318913
Abstract

BACKGROUND

Heparin and low molecular weight heparin are the most frequently used antithromboembolic drugs in fractures.

OBJECTIVES

We aimed to compare the effects of heparin and enoxaparin, which are used as standard treatment, on viability in degloving injuries.

METHODS

Thirty rats were used in the study. Three groups were composed including 10 rats in each group. Degloving injuries were formed in the tails of the rats. Enoxaparin was injected subcutaneously to the rats in group 1. Standard heparin was injected subcutaneously to the rats in group 2. Serum physiologic solution was injected subcutaneously to the rats in group 3. The experiment was ended on day 15. The tails of the rats were evaluated clinically and histopathologically.

RESULTS

There was a statistically significant difference in the clinical results (p < 0.05). There was a statistically significant difference in the histopathological results (p < 0.05).

CONCLUSIONS

We encountered positive effects of both heparin and enoxaparin on the treatment of degloving injuries in this experimental study. However, the findings of this study should be supported and improved by new experimental and especially clinical studies (Fig. 3, Ref. 18).

摘要

背景

肝素和低分子量肝素是骨折治疗中最常用的抗血栓栓塞药物。

目的

我们旨在比较作为标准治疗药物的肝素和依诺肝素对脱套伤组织存活能力的影响。

方法

本研究使用30只大鼠。将其分为三组,每组10只。在大鼠尾部造成脱套伤。对第1组大鼠皮下注射依诺肝素。对第2组大鼠皮下注射标准肝素。对第3组大鼠皮下注射血清生理溶液。实验在第15天结束。对大鼠尾部进行临床和组织病理学评估。

结果

临床结果存在统计学显著差异(p < 0.05)。组织病理学结果存在统计学显著差异(p < 0.05)。

结论

在本实验研究中,我们发现肝素和依诺肝素对脱套伤治疗均有积极作用。然而,本研究结果应通过新的实验研究,尤其是临床研究予以支持和完善(图3,参考文献18)。

相似文献

1
Analysis of the effects of heparin and enoxaparin on degloving injuries.肝素和依诺肝素对脱套伤影响的分析
Bratisl Lek Listy. 2014;115(9):550-3. doi: 10.4149/bll_2014_106.
2
Effects of enoxaparin and rivaroxaban on tissue survival in skin degloving injury: an experimental study.依诺肝素和利伐沙班对皮肤脱套伤组织存活的影响:一项实验研究。
Acta Orthop Traumatol Turc. 2014;48(2):212-6. doi: 10.3944/AOTT.2014.13.0075.
3
Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries.
Microsurgery. 1995;16(10):661-5. doi: 10.1002/micr.1920161002.
4
Effect of hyperbaric oxygen therapy on healing in an experimental model of degloving injury in tails of nicotine-treated rats.高压氧疗法对尼古丁处理大鼠尾部脱套伤实验模型愈合的影响
J Hand Surg Eur Vol. 2013 May;38(4):405-11. doi: 10.1177/1753193412469130. Epub 2012 Dec 7.
5
Investigation of the effects of Enoxaparin, Fondaparinux, and Rivaroxaban used in thromboembolism prophylaxis on fracture healing in rats.探讨依诺肝素、磺达肝癸钠和利伐沙班用于预防血栓栓塞对大鼠骨折愈合的影响。
Eur Rev Med Pharmacol Sci. 2013 Jul;17(14):1850-6.
6
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.低分子量肝素与普通肝素治疗不稳定型冠状动脉疾病的比较。皮下注射依诺肝素治疗非Q波冠状动脉事件研究组的疗效与安全性。
N Engl J Med. 1997 Aug 14;337(7):447-52. doi: 10.1056/NEJM199708143370702.
7
Comparison of effects of unfractionated heparin and low molecular weight heparin on skin wound healing of rats.
Acta Cir Bras. 2012 Sep;27(9):639-44. doi: 10.1590/s0102-86502012000900009.
8
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.低分子量肝素(依诺肝素)与普通肝素治疗不稳定型冠状动脉疾病的随机试验:ESSENCE研究的一年结果。皮下注射依诺肝素在非Q波冠状动脉事件中的疗效和安全性。
J Am Coll Cardiol. 2000 Sep;36(3):693-8. doi: 10.1016/s0735-1097(00)00808-1.
9
A comparison of enoxaparin with unfractionated heparins in patients with coronary heart disease in an emergency department in rural South Indian tertiary care teaching hospital.在印度南部农村三级护理教学医院急诊科,对冠心病患者使用依诺肝素与普通肝素进行比较。
Indian J Pharmacol. 2015 Jan-Feb;47(1):90-4. doi: 10.4103/0253-7613.150360.
10
Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.低分子量肝素依诺肝素在大鼠脑缺血或创伤性脑损伤体内模型中的神经保护作用:综述
CNS Drug Rev. 2002 Spring;8(1):1-30. doi: 10.1111/j.1527-3458.2002.tb00213.x.

引用本文的文献

1
A comparison of rat degloving injury models.大鼠脱套伤模型的比较
Acta Orthop Traumatol Turc. 2017 Jul;51(4):308-312. doi: 10.1016/j.aott.2017.03.007. Epub 2017 Apr 25.